IMARC Group, a leading market research company, has recently releases report titled “Male Infertility Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global Male Infertility market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

How Big Is The Male Infertility Market?

The global male infertility market size reached US$ 3.8 Billion in 2022 Looking forward, IMARC Group expects the market to reach US$ 5.2 Billion by 2028, exhibiting a growth rate (CAGR) of 5.49% during 2023-2028.

What are Male Infertility?

Male infertility lowers the chance of the affected individual to impregnate a fertile woman. It can also occur, owing to abnormal sperm function, blockages, and low sperm production that prevents the delivery of sperm. Genetic defects, undescended testicles, lifestyle choices, diabetes, and infections, such as chlamydia, gonorrhea, mumps, HIV, etc., are some of the common factors that cause male infertility. It can be treated by using vasoepididymostomy, hormone therapy, assisted reproductive technology (ART) procedures, including in vitro fertilization (IVF) and varicocele surgery, etc. These procedures aid in enhancing the reproductive health of males, restoring testosterone levels, improving the quality of sperm to enable pregnancy, etc.

What Are The Growth Prospects And Trends In The Male Infertility Industry?

The growing number of delayed pregnancies and the changing lifestyles of individuals are primarily driving the male infertility market. Additionally, the increasing adoption of deoxyribonucleic acid (DNA) fragmentation techniques and computer-assisted semen analysis to measure semen volume and diagnose hypospermia is further bolstering the market growth. Besides this, the escalating demand for ART procedures, such as IVF, that usually involve the utilization of previously frozen sperms is positively influencing the global market. Moreover, the launch of favorable policies by government bodies across countries to improve reimbursement scenarios for infertility-related treatments and enhance the safety of patient data is acting as another significant growth-inducing factor. Apart from this, the easy availability of several infertility treatment drugs, procedures, and devices is also stimulating the market growth. Furthermore, the rising accessibility to improved healthcare facilities is anticipated to fuel the male infertility market over the forecasted period.

What Is Included In Market Segmentation?

The report has segmented the market into the following categories:

Breakup by Test Type:

  • Sperm Agglutination
  • DNA Fragmentation Technique
  • Oxidative Stress Analysis
  • Computer Assisted Semen Analysis
  • Sperm Penetration Assay
  • Others

Breakup by Treatment:

  • Medication
  • Assisted Reproductive Technology and Varicocele Surgery

Breakup by Distribution Channel:

  • Hospitals Pharmacies
  • Pharmacies and Drug Stores
  • Online Pharmacies

Breakup by End User:

  • Hospitals and Clinics
  • Fertility Centers
  • Research Institutes
  • Others

Market Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

Who Are The Key Players Operating In The Industry?

The report covers the major market players including: 

  • Asahi Kasei Corporation
  • Braun Melsungen AG
  • Baxter International Inc.
  • Becton Dickinson and Company
  • DaVita Inc.
  • Fresenius Medical Care AG & Co. KGaA
  • JMS Co. Ltd.
  • Medtronic plc
  • Nikkiso Co. Ltd.
  • NIPRO Corporation
  • Satellite Healthcare Inc.
  • and Toray Industries Inc.

Ask Analyst For Customization And Browse Full Report With TOC & List Of Figure:

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US


134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: [email protected]

Follow us on Twitter: @imarcglobal